.
New Delhi, April 26 (MondayMirror.com) The Drugs Controller General of India (DCGI) on Tuesday approved the restricted emergency use authorisation (EUA) to Bharat Biotech’s Covaxin for children between the age of 6-12 years, sources said.
The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event with due analysis every 15 days for the first two months and monthly thereafter upto 5 months, said the source familiar with the development.
This development comes after the Subject Expert Committee (SEC) discussed recommendations for the restricted emergency use of Covaxin in children aged between 2-12 years.
However, the SEC, after a meeting on Thursday, had recommended restricted emergency use of Biological E’s Covid-19 vaccine, Corbevax, in children aged 5-12 years.
Source: IANS
Bollywood star Vicky Kaushal recently took to his social media account to warmly wish his…
Aamir Khan's production banner, Aamir Khan Productions, shared a video on their social media account…
Bollywood superstar Salman Khan has taken the internet by storm with his shirtless picture that…
Assam Chief Minister Himanta Biswa Sarma's claim on Monday that popular singer Zubeen Garg's death…
Bollywood’s young star Suhana Khan, daughter of Shah Rukh Khan, is again in the spotlight.…
Filmmaker Ram Gopal Varma will soon be treating the movie buffs with his forthcoming horror…